TerminatedPhase 2

ZP120 Add-on to Furosemide in Treatment of Acute or Sub-Acute Decompensated Heart Failure

NCT00283361

What is this trial?

Generating plain-language summary...

Generating eligibility summary...

Summarizing study design...

Primary location

LAC-USC Medical Center-Division of Cardiology

Los Angeles, California, United States

+21 additional locations

Save this trial

LAC-USC Medical Center-Division of CardiologyLos Angeles, California, United States
VA Medical Center -WLALos Angeles, California, United States
UCSD Medical CenterSan Diego, California, United States
San Francisco VA Medical CenterSan Francisco, California, United States
University of CO Health Sciences CenterDenver, Colorado, United States
Health First Clinical Research InstituteMelbourne, Florida, United States
Univ. of Miami Miller School of Medicine, Jackson Memorial Medical CenterMiami, Florida, United States
Emory University Hospital/The Emory ClinicAtlanta, Georgia, United States
Northside HospitalAtlanta, Georgia, United States
Rush University Medical CenterChicago, Illinois, United States
Community Hospital Anderson/Community Clinical Research CenterAnderson, Indiana, United States
University of Iowa Heart Failure Treatment ProgramIowa City, Iowa, United States
University of MarylandBaltimore, Maryland, United States
Henry Ford HospitalDetroit, Michigan, United States
Hennepin County Medical CenterMinneapolis, Minnesota, United States
The International Heart InstituteMissoula, Montana, United States
Bryan LGH Heart InstituteLincoln, Nebraska, United States
University of Rochester Medical CenterRochester, New York, United States
Cleveland Clinic FoundationCleveland, Ohio, United States
Lancaster Heart FoundationLancaster, Pennsylvania, United States
Albert Einstein Medical CenterPhiladelphia, Pennsylvania, United States
Alamo Clinical Research AssociatesSan Antonio, Texas, United States